Picard Medical gets NYSE American nod on compliance plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Picard Medical Receives NYSE American Acceptance of Compliance Plan
July 27, 2026 7:00 AM EDTTUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the Company or Picard Medical), parent company of SynCardia Systems LLC, maker of the worlds first and only total artificial heart approved by both the U.S. FDA and Health Canada, today announced that the NYSE American LLC (NYSE American) has accepted the Companys plan to regain compliance with the exchanges continued listing standards under Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
The acceptance of the Companys compliance plan allows Picard Medical to continue listing and trading... More



